10-K Filing

LifeMD, Inc. CIK: 948320 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001213900-18-003893`
Period End Date	20171231
Filing Date	20180402
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	immd-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 60 Income Statement 38 Cash Flow Statement 69 Stockholders Equity 33

Balance Sheet 60 line items

Line Item	Tag	Value	Unit	Period
Treasury stock, shares	`TreasuryStockCommonShares`	515,200.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	325,000.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$141.38K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$444.74K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	35.57M	shares	Point-in-time
Trade accounts receivable, net	`AccountsReceivableNetCurrent`	$398.77K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	200,000.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	434,782.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	44.49M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	217,391.00	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.98M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$2.25K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	35.25M	shares	Point-in-time
Product deposit	`DepositAssets`	-	USD	Point-in-time
Product deposit	`DepositAssets`	$16.50K	USD	Point-in-time
Inventory, net	`InventoryNet`	$707.16K	USD	Point-in-time
Inventory, net	`InventoryNet`	$160.27K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.26M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$789.82K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$473.49K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$752.93K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$192.25K	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$42.48K	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	-	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Convertible notes payable	`ConvertibleNotesPayableCurrent`	$100.00K	USD	Point-in-time
Notes payable - related parties	`NotesPayableRelatedPartiesClassifiedCurrent`	-	USD	Point-in-time
Notes payable - related parties	`NotesPayableRelatedPartiesClassifiedCurrent`	$125.00K	USD	Point-in-time
Short-term notes payable, net of discount in 2016	`NotesPayableCurrent`	$106.36K	USD	Point-in-time
Short-term notes payable, net of discount in 2016	`NotesPayableCurrent`	-	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$640.97K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.15M	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 44,493,063 and 35,570,157 shares issued, 43,977,863 and 35,245,157 outstanding as of December 31, 2017 and 2016, respectively	`CommonStockValue`	$355.70K	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 44,493,063 and 35,570,157 shares issued, 43,977,863 and 35,245,157 outstanding as of December 31, 2017 and 2016, respectively	`CommonStockValue`	$46.00K	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 44,493,063 and 35,570,157 shares issued, 43,977,863 and 35,245,157 outstanding as of December 31, 2017 and 2016, respectively	`CommonStockValue`	$444.93K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$11.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.07M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-9.69M	USD	Point-in-time
Accumulated (deficit)	`RetainedEarningsAccumulatedDeficit`	$-10.90M	USD	Point-in-time
Equity	`Equity`	$1.05M	USD	Point-in-time
Equity	`Equity`	$-268.12K	USD	Point-in-time
Treasury stock, 515,200 and 325,000 shares, at cost	`TreasuryStockValue`	$87.05K	USD	Point-in-time
Treasury stock, 515,200 and 325,000 shares, at cost	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$-355.17K	USD	Point-in-time
Total Immudyne, Inc. Stockholders' (Deficit)	`StockholdersEquity`	$881.92K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-259.08K	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-6.55K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$622.84K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.26M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$789.82K	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Net Sales	`Revenues`	$5.05M	USD	Annual
Net Sales	`Revenues`	$5.24M	USD	Annual
Cost of Sales	`CostOfRevenue`	$1.95M	USD	Annual
Cost of Sales	`CostOfRevenue`	$1.48M	USD	Annual
Gross Profit	`GrossProfit`	$3.57M	USD	Annual
Gross Profit	`GrossProfit`	$3.29M	USD	Annual
Compensation and related expenses	`LaborAndRelatedExpense`	$1.25M	USD	Annual
Compensation and related expenses	`LaborAndRelatedExpense`	$1.70M	USD	Annual
Professional fees	`ProfessionalFees`	$431.33K	USD	Annual
Professional fees	`ProfessionalFees`	$477.40K	USD	Annual
Marketing expenses	`MarketingExpense`	$1.66M	USD	Annual
Marketing expenses	`MarketingExpense`	$1.71M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.03M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$851.26K	USD	Annual
Total operating expenses	`OperatingExpenses`	$4.64M	USD	Annual
Total operating expenses	`OperatingExpenses`	$4.47M	USD	Annual
Operating (Loss)	`OperatingIncomeLoss`	$-1.07M	USD	Annual
Operating (Loss)	`OperatingIncomeLoss`	$-1.17M	USD	Annual
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	-	USD	Annual
Change in fair value of derivative liability	`ChangeInFairValueOfDerivativeLiability`	$-502.83K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-553.22K	USD	Annual
Interest (expense)	`InterestExpense`	$48.61K	USD	Annual
Interest (expense)	`InterestExpense`	$100.52K	USD	Annual
Net Income (Loss)	`ProfitLoss`	$-1.22M	USD	Annual
Net Income (Loss)	`ProfitLoss`	$-1.22M	USD	Annual
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-12.49K	USD	Annual
Net (loss) income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-115.75K	USD	Annual
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-1.21M	USD	Annual
Net Income (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-1.11M	USD	Annual
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.03	USD	Annual
Basic income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareBasic`	$-0.03	USD	Annual
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.03	USD	Annual
Diluted income (loss) per share attributable to Immudyne, Inc.	`EarningsPerShareDiluted`	$-0.03	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	41.74M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	33.48M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	41.74M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	33.48M	shares	Annual

Cash Flow Statement 69 line items

Line Item	Tag	Value	Unit	Period
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-1.21M	USD	Annual
Net (loss) attributable to Immudyne, Inc.	`NetIncomeLoss`	$-1.11M	USD	Annual
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-12.49K	USD	Annual
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-115.75K	USD	Annual
Net (Loss)	`ProfitLoss`	$-1.22M	USD	Annual
Net (Loss)	`ProfitLoss`	$-1.22M	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	-	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInDerivativeLiabilities`	$-502.83K	USD	Annual
Bad debt provision (recovery)	`ProvisionForDoubtfulAccounts`	$71.14K	USD	Annual
Bad debt provision (recovery)	`ProvisionForDoubtfulAccounts`	$-49.12K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$91.56K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$33.72K	USD	Annual
Loss on settlement of notes and other payables	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Loss on settlement of notes and other payables	`GainsLossesOnExtinguishmentOfDebt`	$-553.22K	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$587.99K	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$162.74K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$838.94K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$361.44K	USD	Annual
Trade accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-95.09K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-2.25K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$2.25K	USD	Annual
Product deposit	`IncreaseDecreaseInDeposits`	$-16.50K	USD	Annual
Product deposit	`IncreaseDecreaseInDeposits`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$99.22K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$546.89K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$585.45K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-227.23K	USD	Annual
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-817.22K	USD	Annual
Net cash (used) by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-407.91K	USD	Annual
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$219.89K	USD	Annual
Investment in subsidiary by noncontrolling interest, net	`ProceedsFromPaymentsToMinorityShareholders`	$63.38K	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$200.00K	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$100.00K	USD	Point-in-time
Proceeds from notes payable	`ProceedsFromNotesPayable`	$878.86K	USD	Annual
Proceeds from convertible note payable	`ProceedsFromConvertibleDebt`	$100.00K	USD	Annual
Proceeds from convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	Annual
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Repayment of convertible note payable	`RepaymentsOfConvertibleDebt`	$100.00K	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$662.80K	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$168.60K	USD	Annual
Proceeds from options exercise	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Proceeds from options exercise	`ProceedsFromStockOptionsExercised`	$30.00K	USD	Annual
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	$673.25K	USD	Annual
Sale of common stock and warrants	`IssuanceOfCommonStockAndWarrants`	$63.25K	USD	Annual
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-76.65K	USD	Annual
Purchase of treasury stock	`ProceedsFromIssuanceOfCommonStock`	$-87.05K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$357.49K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$776.03K	USD	Annual
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-41.18K	USD	Annual
Net increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-50.42K	USD	Annual
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$141.38K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$141.38K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$232.98K	USD	Point-in-time
Cash at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$182.56K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaid`	$13.65K	USD	Annual
Cash paid during the period for interest	`InterestPaid`	$4.72K	USD	Annual
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	-	USD	Annual
Issuance of company stock for notes and other payables	`ConversionOfStockAmountIssued1`	$242.19K	USD	Annual
Issuance of common stock in relation to debt offering	`IssuanceOfCommonStockInRelationDebtOffering`	-	USD	Annual
Issuance of common stock in relation to debt offering	`IssuanceOfCommonStockInRelationDebtOffering`	$58.75K	USD	Annual
Issuance of common stock for services	`IssuanceOfCommonStockForServices`	$100.00K	USD	Annual
Issuance of common stock for services	`IssuanceOfCommonStockForServices`	-	USD	Annual
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	$303.42K	USD	Annual
Conversion of equity invested in subsidiary to common stock and warrants	`ConversionOfEquityInvestedInSubsidiaryToCommonStockAndWarrants`	-	USD	Annual
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	$261.36K	USD	Annual
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`ReclassificationOfOptionsWarrantsAndOtherContractsToDerivativeLiabilities`	$192.25K	USD	Annual

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$622.84K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time
Amortization of stock options	`AdjustmentsOfAdditionPaidInCapitalAmortizationOfStockOptions`	$120.87K	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$838.94K	USD	Annual
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$383.33K	USD	Annual
Sale of common stock and warrants	`StockIssuedDuringPeriodValueNewIssues`	$63.25K	USD	Annual
Sale of common stock and warrants	`StockIssuedDuringPeriodValueNewIssues`	$673.25K	USD	Annual
Conversion of NCI equity for shares	`StockIssuedDuringPeriodConversionOfNonControllingEquityForShares`	$100.00K	USD	Annual
Issuance of common stock for options exercise	`StockIssuedDuringPeriodValueStockOptionsExercised`	$30.00K	USD	Annual
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$58.75K	USD	Annual
Issuance of common stock in relation to debt offering	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$56.52K	USD	Annual
Issuance of common stock in relation to debt offering, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	62,500.00	shares	3 Qtrs
Issuance of warrants for services	`AdjustmentOfWarrantsGrantedForServices`	$20.59K	USD	Annual
Reduction in noncontrolling interest	`MinorityInterestPeriodIncreaseDecrease`	-	USD	Annual
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$87.05K	USD	Annual
Purchase of treasury stock	`TreasuryStockValueAcquiredCostMethod`	$76.65K	USD	Annual
Issuance of stock options for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$113.52K	USD	Annual
Issuance of stock options for services	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$63.21K	USD	Annual
Investment in subsidiary by noncontrolling interest, net of distributions	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$63.38K	USD	Annual
Investment in subsidiary by noncontrolling interest, net of distributions	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$119.89K	USD	Annual
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationReclassificationOfOptionsWarrantsAndOtherContractsFromEquityToDerivativeLiabilities`	$-192.25K	USD	Annual
Reclassification of options, warrants and other contracts to derivative liabilities upon issuance	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationReclassificationOfOptionsWarrantsAndOtherContractsFromEquityToDerivativeLiabilities`	$-261.36K	USD	Annual
Conversion of non-controlling interest equity for shares and warrants	`StockIssuedDuringPeriodValueConversionOfUnits`	-	USD	Annual
Conversion of note payable	`StockIssuedDuringPeriodValueOther`	$192.19K	USD	Annual
Loss on settlement of notes and other payables	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$553.22K	USD	Annual
Conversion of accrued expenses	`StockIssuedDuringPeriodValueConversionOfAccruedExpenses`	$50.00K	USD	Annual
Cashless exercise of options	`CashlessExerciseOfOptions`	-	USD	Annual
Net (loss)	`ProfitLoss`	$-1.22M	USD	Annual
Net (loss)	`ProfitLoss`	$-1.22M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.99K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$622.84K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-361.73K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.